The Oncology Institute, Inc.TOIIWNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank33
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P33
Within normal range
vs 5Y Ago
-175.3x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2024$-53.83M+0.8%
2023$-54.28M+19.7%
2022$-67.60M-60.8%
2021$-42.04M-272.4%
2020$-11.29M-3776.2%
2019$307109.00-96.6%
2018$9.08M-